Landiolol
New Drug Approvals
APRIL 19, 2025
Baker JG (February 2005). “Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction” International Journal of Cardiology. 2016 Apr 25;80(5):1106-7 ^ “Rapibloc Summary of Product Characteristics” (PDF).
Let's personalize your content